Literature DB >> 8793108

Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1.

J Z Wang1, I Grundke-Iqbal, K Iqbal.   

Abstract

Microtubule associated protein tau promotes the assembly of microtubules by binding to microtubules and stabilizing their structure. In Alzheimer disease brain, tau is abnormally hyperphosphorylated and the altered tau is unable to promote the in vitro assembly of microtubules. In the present study, we found that dephosphorylation of abnormally phosphorylated tau by protein phosphatase-2A1, -2B or -1 restored its biological activity both in the nucleation and in the assembly of microtubules. Both the amount of phosphate released and the rate of restoration of microtubule assembly promoting activity of the abnormal tau were greater on dephosphorylation by protein phosphatase-2A1 than -2B or -1. During 90 min incubation at 37 degrees C protein phosphatase-2A1, -2B and -1 released respectively approximately 57%, approximately 36% and approximately 30% of tau phosphate. Association of the restoration of the biological activity of the abnormal tau dephosphorylated by different phosphatases and the immunochemical identification of the dephosphorylated sites revealed that Ser-235 is not critical in tau function, and that the Thr-231 is probably involved in the regulation of the nucleation and not the assembly of microtubules. These studies indicate that the phosphorylation of tau in situ might be regulated by protein phosphatase-2A, -2B and -1 and activation of these enzyme activities might arrest the Alzheimer neurofibrillary degeneration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793108     DOI: 10.1016/0169-328x(95)00316-k

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  62 in total

1.  Multiple forms of phosphatase from human brain: isolation and partial characterization of affi-gel blue binding phosphatases.

Authors:  L Y Cheng; J Z Wang; C X Gong; J J Pei; T Zaidi; I Grundke-Iqbal; K Iqbal
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

Review 2.  Tau pathology generated by overexpression of tau.

Authors:  I Grundke-Iqbal; K Iqbal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Physiological regulation of tau phosphorylation during hibernation.

Authors:  Bo Su; Xinglong Wang; Kelly L Drew; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Neurochem       Date:  2008-06-01       Impact factor: 5.372

Review 4.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 5.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 6.  Tau in Alzheimer disease and related tauopathies.

Authors:  K Iqbal; F Liu; C-X Gong; I Grundke-Iqbal
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

7.  Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.

Authors:  Alejandra del C Alonso; Bin Li; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-30       Impact factor: 11.205

Review 8.  Anesthesia and tau pathology.

Authors:  Robert A Whittington; Alexis Bretteville; Maya F Dickler; Emmanuel Planel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-25       Impact factor: 5.067

Review 9.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

Review 10.  Improved behavioral response as a valid biomarker for drug screening program in transgenic rodent models of tauopathies.

Authors:  Miroslava Korenova; Zuzana Stozicka
Journal:  Cell Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.